Except for NOS1, DNMT1 and CCL5, the hub genes CCL19 and CCR7 in DE-GRGs are compose of the CCL19/CCL21-CCR7 axis that exerts both immune response and tumor proliferation 36. The gene discussed is CCR7; the disease is neoplasm.